FDA Approves Xdemvy for Demodex Blepharitis
FRIDAY, July 28, 2023 -- The U.S. Food and Drug Administration has approved Xdemvy (lotilaner ophthalmic solution) 0.25 percent for the treatment of Demodex blepharitis, caused by Demodex mites.
The approval was based on results from two... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 28, 2023 Category: General Medicine Source Type: news
First Treatment for Demodex Blepharitis Wins FDA Approval
(MedPage Today) -- The FDA approved lotilaner ophthalmic solution 0.25% (Xdemvy) as the first specific treatment for Demodex blepharitis.
Lotilaner (formerly TP-03) is an ectoparasiticide that targets Demodex mites, which invade and reside in... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 26, 2023 Category: American Health Source Type: news
FDA Approves Xdemvy (lotilaner) Ophthalmic Solution for the Treatment of Demodex Blepharitis
IRVINE, Calif., July 25, 2023 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care,... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 25, 2023 Category: Drugs & Pharmacology Source Type: news
Highlights in Corneal Disorders From AAO 2022 Highlights in Corneal Disorders From AAO 2022
Key data in corneal disorders from AAO include a nontransplant therapy for Fuchs dystrophy, data on corneal adverse events from a myeloma drug, and positive data on lotilaner for Demodex blepharitis.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 21, 2022 Category: Consumer Health News Tags: None ReCAP Source Type: news
Tarsus Submits New Drug Application to the FDA for TP-03 for the Treatment of Demodex Blepharitis
IRVINE, Calif., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - September 7, 2022 Category: Drugs & Pharmacology Source Type: news
Woman says menopause symptoms made her look like a 'demon monster' due to blepharitis
A 55 YEAR-OLD woman from Rochester said that one of the symptoms of her menopause made her look like a "demon monster". (Source: Daily Express - Health)
Source: Daily Express - Health - April 16, 2022 Category: Consumer Health News Source Type: news
Blepharitis: Three signs you could have the same condition as The Chase host Bradley Walsh
BLEPHARITIS commonly occurs when tiny oil glands near the base of the eyelashes become clogged. In serious cases it could mean surgery but what are the early warning signs to look out for to help prevent the condition from becoming worse? (Source: Daily Express - Health)
Source: Daily Express - Health - July 29, 2021 Category: Consumer Health News Source Type: news
Blepharitis symptoms: When to go to the doctors about inflamed eyelids
BLEPHARITIS is an infection that affects the eyelids and eyelashes, but it's normally nothing serious. When should you see a doctor about blepharitis? (Source: Daily Express - Health)
Source: Daily Express - Health - July 11, 2021 Category: Consumer Health News Source Type: news
December 2020
Bacteria Treatment Improves Children ’s Eczema
Harmful Partnerships : When Someone You Love is Abusive
Eyelid Trouble? : Managing Blepharitis
Donate Your Brain for Research
Bone, Joint, Muscle,& Skin Health for Kids (Source: NIH News in Health)
Source: NIH News in Health - December 4, 2020 Category: Consumer Health News Source Type: news
December 2020
Bacteria Treatment Improves Children ’s Eczema
Harmful Partnerships : When Someone You Love is Abusive
Eyelid Trouble? : Managing Blepharitis
Donate Your Brain for Research
Bone, Joint, Muscle,& Skin Health for Kids (Source: NIH News in Health)
Source: NIH News in Health - November 23, 2020 Category: Consumer Health News Source Type: news
What Are the Symptoms of Herpes Simplex Keratitis?
Discussion
Herpes simplex virus (HSV) infections are common with an estimated 50% of the US population being infected by age 30, and with latent infection harboring in the trigeminal nerve in 100% of people by age 60 years. HSV infections can cause a vesicular or pustular skin rash that is painful, burning or pruritic and also flu-like symptoms with fever, chills, headache, and fatigue. HSV can also be asymptomatic.
To laymen, herpes simplex viruses cause “cold sores,” but to health care personnel, herpes causes many systemic infections including eczema herpeticum, folliculitis, herpes gladiatorum, whitlow, e...
Source: PediatricEducation.org - October 5, 2020 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Bradley Walsh health: 'I really struggle' - The Chase host explains itchy condition
BRADLEY WALSH is the host of ITV's The Chase, and he'll be back on our televisions on Sunday night, as the Chasers take on a celebrity special. The TV star has previously explained the details of his eye condition, admitting that he can really struggle without medication. These are the blepharitis signs and symptoms. (Source: Daily Express - Health)
Source: Daily Express - Health - May 31, 2020 Category: Consumer Health News Source Type: news
What Is the Main Cause of Blepharitis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 27, 2020 Category: General Medicine Source Type: news
French pharma moves U.S. base to RTP from Texas
French pharmaceutical company Nicox has opened its new U.S. development office in Research Triangle Park, moving it from Fort Worth, Texas.
The opening of the office comes as Nicox is looking to begin phase 2 clinical studies of product candidates for glaucoma and blepharitis – an inflammation of the eyelid.
In the Triangle area, Nicox was able to hire all of the team members it needed to get started within a month, says Gavin Spen cer, executive vice president and chief business officer.
The… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 25, 2018 Category: American Health Authors: Jennifer Henderson Source Type: news
French pharma moves U.S. base to RTP from Texas
French pharmaceutical company Nicox has opened its new U.S. development office in Research Triangle Park, moving it from Fort Worth, Texas.
The opening of the office comes as Nicox is looking to begin phase 2 clinical studies of product candidates for glaucoma and blepharitis – an inflammation of the eyelid.
In the Triangle area, Nicox was able to hire all of the team members it needed to get started within a month, says Gavin Spen cer, executive vice president and chief business officer.
The… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - April 25, 2018 Category: Biotechnology Authors: Jennifer Henderson Source Type: news
